CIK 0001829280
FORA Forian Inc.
Insider trading from SEC Form 4. Last filing May 15, 2026.
Forian Inc. (FORA) has 39 SEC Form 4 filings on file from 10 insiders, the latest filed on May 15, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
2 open-market trades have been scored at FORA. The newest: Max C Wygod (Exec Chairman, CEO & President) bought $2,605 of stock on Feb 14, 2025, filed Feb 18, 2025, scored 25 (weak). The largest of the 2 shown: Max C Wygod (Exec Chairman, CEO & President) bought $42k on Feb 11, 2025, scored 31 (weak).
Last 90 days
Signals
Open-market buys and sells at Forian Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 25Weak | Max C Wygod Exec Chairman, CEO & President buy | $2,605 880 shares | +0% | - | |
| 31Weak | Max C Wygod Exec Chairman, CEO & President buy | $42k 15,867 shares | +1% | - |
Transactions
The newest 50 of 90 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 15, 2026 | Alyssa F Varadhan director | UTender of shares Common Stock | -5,000 | - | - | 0 | May 15, 2026 |
| May 15, 2026 | Max C Wygod Exec Chairman, CEO & President | DDisposition to issuer Common Stock | -1,278,927 | - | - | 0 | May 15, 2026 |
| May 15, 2026 | Michael Vesey Chief Financial Officer | UTender of shares Common Stock | -139,610 | - | - | 450,000 | May 15, 2026 |
| May 15, 2026 | Adam H Dublin Chief Strategy Officer | DDisposition to issuer Common Stock | -2,455,533 | - | - | 0 | May 15, 2026 |
| May 15, 2026 | Ian Banwell director | UTender of shares Common Stock | -5,000 | - | - | 0 | May 15, 2026 |
| May 15, 2026 | Jennifer Hajj director | UTender of shares Common Stock | -5,000 | - | - | 0 | May 15, 2026 |
| May 15, 2026 | Caroline Strickland McGrail General Counsel | DDisposition to issuer Common Stock | -150,000 | - | - | 0 | May 15, 2026 |
| May 15, 2026 | Kristiina Vuori MD director | UTender of shares Common Stock | -28,757 | - | - | 0 | May 15, 2026 |
| May 15, 2026 | Mark J Adler Md director | UTender of shares Common Stock | -37,583 | - | - | 0 | May 15, 2026 |
| May 15, 2026 | Shahir Kassam-Adams director | DDisposition to issuer Common Stockindirect: By 360 Ventures, LLC | -171,184 | - | - | 0 | May 15, 2026 |
| May 15, 2026 | Ian Banwell director | UTender of shares Common Stockindirect: By Spouse | -99,784 | - | - | 0 | May 15, 2026 |
| May 15, 2026 | Jennifer Hajj director | UTender of shares Common Stockindirect: By Spouse | -5,000 | - | - | 0 | May 15, 2026 |
| May 15, 2026 | Shahir Kassam-Adams director | DDisposition to issuer Common Stock | -5,000 | - | - | 0 | May 15, 2026 |
| May 15, 2026 | Kristiina Vuori MD director | DDisposition to issuer Stock Option (right to buy)derivative | +15,000 | - | - | 0 | May 15, 2026 |
| May 15, 2026 | Alyssa F Varadhan director | DDisposition to issuer Stock Option (right to buy)derivative | +15,000 | - | - | 0 | May 15, 2026 |
| May 15, 2026 | Max C Wygod Exec Chairman, CEO & President | DDisposition to issuer Common Stock | -250,000 | - | - | 0 | May 15, 2026 |
| May 15, 2026 | Mark J Adler Md director | DDisposition to issuer Stock Option (right to buy)derivative | +15,000 | - | - | 0 | May 15, 2026 |
| May 15, 2026 | Adam H Dublin Chief Strategy Officer | DDisposition to issuer Common Stock | -250,000 | - | - | 0 | May 15, 2026 |
| May 15, 2026 | Michael Vesey Chief Financial Officer | DDisposition to issuer Common Stock | -450,000 | - | - | 0 | May 15, 2026 |
| May 15, 2026 | Michael Vesey Chief Financial Officer | DDisposition to issuer Stock Option (right to buy)derivative | +175,000 | - | - | 0 | May 15, 2026 |
| May 15, 2026 | Jennifer Hajj director | DDisposition to issuer Stock Option (right to buy)derivative | -15,000 | - | - | 0 | May 15, 2026 |
| May 15, 2026 | Ian Banwell director | DDisposition to issuer Stock Option (right to buy)derivative | +15,000 | - | - | 0 | May 15, 2026 |
| May 15, 2026 | Shahir Kassam-Adams director | DDisposition to issuer Stock Option (right to buy)derivative | +15,000 | - | - | 0 | May 15, 2026 |
| May 15, 2026 | Adam H Dublin Chief Strategy Officer | DDisposition to issuer Common Stockindirect: Adam Dublin Family Trust | -1,831,526 | - | - | 0 | May 15, 2026 |
| May 15, 2026 | Kristiina Vuori MD director | DDisposition to issuer Stock Option (right to buy)derivative | +15,000 | - | - | 0 | May 15, 2026 |
| May 15, 2026 | Alyssa F Varadhan director | DDisposition to issuer Stock Option (right to buy)derivative | +15,000 | - | - | 0 | May 15, 2026 |
| May 15, 2026 | Mark J Adler Md director | DDisposition to issuer Stock Option (right to buy)derivative | +15,000 | - | - | 0 | May 15, 2026 |
| May 15, 2026 | Michael Vesey Chief Financial Officer | DDisposition to issuer Stock Option (right to buy)derivative | +185,000 | - | - | 0 | May 15, 2026 |
| May 15, 2026 | Mark J Adler Md director | DDisposition to issuer Stock Option (right to buy)derivative | +15,000 | - | - | 0 | May 15, 2026 |
| May 15, 2026 | Jennifer Hajj director | DDisposition to issuer Stock Option (right to buy)derivative | -15,000 | - | - | 0 | May 15, 2026 |
| May 15, 2026 | Alyssa F Varadhan director | DDisposition to issuer Stock Option (right to buy)derivative | +15,000 | - | - | 0 | May 15, 2026 |
| May 15, 2026 | Shahir Kassam-Adams director | DDisposition to issuer Stock Option (right to buy)derivative | +15,000 | - | - | 0 | May 15, 2026 |
| May 15, 2026 | Ian Banwell director | DDisposition to issuer Stock Option (right to buy)derivative | +15,000 | - | - | 0 | May 15, 2026 |
| May 15, 2026 | Kristiina Vuori MD director | DDisposition to issuer Stock Option (right to buy)derivative | +15,000 | - | - | 0 | May 15, 2026 |
| May 15, 2026 | Michael Vesey Chief Financial Officer | DDisposition to issuer Stock Option (right to buy)derivative | +200,000 | - | - | 0 | May 15, 2026 |
| May 15, 2026 | Mark J Adler Md director | DDisposition to issuer Stock Option (right to buy)derivative | +15,000 | - | - | 0 | May 15, 2026 |
| May 15, 2026 | Jennifer Hajj director | DDisposition to issuer Stock Option (right to buy)derivative | -15,000 | - | - | 0 | May 15, 2026 |
| May 15, 2026 | Alyssa F Varadhan director | DDisposition to issuer Stock Option (right to buy)derivative | +15,000 | - | - | 0 | May 15, 2026 |
| May 15, 2026 | Ian Banwell director | DDisposition to issuer Stock Option (right to buy)derivative | +15,000 | - | - | 0 | May 15, 2026 |
| May 15, 2026 | Shahir Kassam-Adams director | DDisposition to issuer Stock Option (right to buy)derivative | +15,000 | - | - | 0 | May 15, 2026 |
| May 15, 2026 | Kristiina Vuori MD director | DDisposition to issuer Stock Option (right to buy)derivative | +15,000 | - | - | 0 | May 15, 2026 |
| May 15, 2026 | Michael Vesey Chief Financial Officer | DDisposition to issuer Stock Option (right to buy)derivative | +350,000 | - | - | 0 | May 15, 2026 |
| May 15, 2026 | Jennifer Hajj director | DDisposition to issuer Stock Option (right to buy)derivative | -15,000 | - | - | 0 | May 15, 2026 |
| May 15, 2026 | Alyssa F Varadhan director | DDisposition to issuer Stock Option (right to buy)derivative | +15,000 | - | - | 0 | May 15, 2026 |
| May 15, 2026 | Ian Banwell director | DDisposition to issuer Stock Option (right to buy)derivative | +15,000 | - | - | 0 | May 15, 2026 |
| May 15, 2026 | Shahir Kassam-Adams director | DDisposition to issuer Stock Option (right to buy)derivative | +15,000 | - | - | 0 | May 15, 2026 |
| May 15, 2026 | Mark J Adler Md director | DDisposition to issuer Stock Option (right to buy)derivative | +15,000 | - | - | 0 | May 15, 2026 |
| May 15, 2026 | Kristiina Vuori MD director | DDisposition to issuer Stock Option (right to buy)derivative | +15,000 | - | - | 0 | May 15, 2026 |
| May 15, 2026 | Jennifer Hajj director | DDisposition to issuer Stock Option (right to buy)derivative | -15,000 | - | - | 0 | May 15, 2026 |
| May 15, 2026 | Ian Banwell director | DDisposition to issuer Stock Option (right to buy)derivative | +15,000 | - | - | 0 | May 15, 2026 |
Insiders
Everyone who has filed a Form 4 here.
- Mark J Adler Mddirector
- Ian Banwelldirector
- Adam H DublinChief Strategy Officer
- Jennifer Hajjdirector
- Shahir Kassam-Adamsdirector
- Caroline Strickland McGrailGeneral Counsel
- Michael VeseyChief Financial Officer
- Alyssa F Varadhandirector
- Kristiina Vuori MDdirector
- Max C WygodExec Chairman, CEO & President
Questions about FORA
Answered from the filings on this page, as of the latest one.
Are insiders buying FORA?
No. In the last 90 days no insider at Forian Inc. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade FORA on the open market?
Max C Wygod (Exec Chairman, CEO & President) bought $2,605 of FORA on Feb 14, 2025 and filed the Form 4 on Feb 18, 2025. InsiderTell scored 25 (weak).
How many insiders file Form 4 at Forian Inc.?
10 people have filed a Form 4 at Forian Inc., among them Mark J Adler Md (director), Ian Banwell (director), Adam H Dublin (Chief Strategy Officer). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.